Cite

MLA Citation

    Karthik Lingineni et al.. “Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment.” Clinical pharmacology & therapeutics, vol. 109, no. 1, 2021, pp. 193–200. http://access.bl.uk/ark:/81055/vdc_100118096762.0x000064
  
Back to record